Pyruvate Kinase Deficiency clinical trials at UCSF

1 in progress, 0 open to eligible people

AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007
Sorry, in progress, not accepting new patients
This is a multicenter, open-label, extension study to evaluate the long-term safety, tolerability, and efficacy of treatment with AG-348 in participants who were previously enrolled in Study AG348-C-006 or Study AG348-C-007.
Oakland, California and other locations

Last updated: September 19, 2023